This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Nepal received 1 million doses of Covishield vaccine bought from India’s Serum Institute
(G.N.S) Dt. 22 Kathmandu Oxford-AstraZeneca’s Covishield is being manufactured by Pune-based Serum Institute of India (SII) which has collaborated with Oxford University and pharmaceutical company AstraZeneca for making the vaccine. In a fight against Pandemic Covid-19, Nepal has received the one million doses of Covishield vaccine it bought from India’s